Literature DB >> 2883434

Treatment failure of ofloxacin in Campylobacter pylori infection.

Y Glupczynski, M Labbe, A Burette, M Delmee, V Avesani, C Bruck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2883434     DOI： 10.1016/s0140-6736(87)90527-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  23 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  In vitro and in vivo activities of HPi1, a selective antimicrobial against Helicobacter pylori.

Authors:  Ekaterina Gavrish; Binu Shrestha; Chao Chen; Ida Lister; E Jeffrey North; Lei Yang; Richard E Lee; Angel Han; Bronwyn Williams; David Charnuska; Ken Coleman; Kim Lewis; Michael D LaFleur
Journal:  Antimicrob Agents Chemother       Date:  2014-03-31       Impact factor: 5.191

3.  Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pylori.

Authors:  T Iwahi; H Satoh; M Nakao; T Iwasaki; T Yamazaki; K Kubo; T Tamura; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

4.  Animal model of Helicobacter pylori infection.

Authors:  Y Glupczynski; A Burette
Journal:  Antimicrob Agents Chemother       Date:  1990-07       Impact factor: 5.191

5.  Role of metronidazole resistance in therapy of Helicobacter pylori infections.

Authors:  H Rautelin; K Seppälä; O V Renkonen; U Vainio; T U Kosunen
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191

Review 6.  Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors:  P A Todd; D Faulds
Journal:  Drugs       Date:  1991-11       Impact factor: 9.546

7.  In vitro activities of new quinolones against Helicobacter pylori.

Authors:  M Carbone; M T Fera; V Cecchetti; O Tabarrini; E Losi; V Cusumano; G Teti
Journal:  Antimicrob Agents Chemother       Date:  1997-12       Impact factor: 5.191

8.  Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents.

Authors:  M L Grayson; G M Eliopoulos; M J Ferraro; R C Moellering
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

9.  Comparative in vitro activities of six new fluoroquinolones and other oral antimicrobial agents against Campylobacter pylori.

Authors:  A E Simor; S Ferro; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

10.  Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cells.

Authors:  K Nagata; H Satoh; T Iwahi; T Shimoyama; T Tamura
Journal:  Antimicrob Agents Chemother       Date:  1993-04       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.